Guangdong Province, CN
SKU Liraglutide
Liraglutide
Liraglutide 3.0 can reduce glycosylated hemoglobin
Price on request
No public price on this one — ask the supplier for a quote.
Details
CAS.NO: 204656-20-2
Liraglutide 3.0 can reduce glycosylated hemoglobin, and it has been shown to be beneficial to cardiovascular treatment in typeⅡ diabetic patients with atherosclerotic cardiovascular disease with coronary heart disease, ischemic stroke, and peripheral artery disease.
Insulin Degludec and Liraglutide Transport and Storage Stability
Transportation stability: It is transported in an ice pack to keep it active.
Storage stability: The product can be stored for at least 24 months at -15°C below.
Notice and Disclaimer
Pollution should be avoided during operation.
The product should not be used for diagnosis or treatment of animals or humans.
If you want to know more about liraglutide in type 1 diabetes, please visit our website.
As a biopharmaceutical company, we can offer kinds of Pharmaceutical raw materials for sale, anything you need, please contact us.